Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Study Shows Euromed's Spanish Olive Fruit Extract (SOFE) to Have Promising Heart Health Benefits
  • USA - English


News provided by

Bryer Advertising & Public Relations

Feb 01, 2017, 07:00 ET

Share this article

Share toX

Share this article

Share toX

PhytoProof, To BE SURE
PhytoProof, To BE SURE

(PRWEB) February 01, 2017 -- A new published study delivers promise for everyone concerned about heart health. According to the Center for Disease Control (CDC), heart disease is the leading cause of death in the US for both men and women. People of all ages and backgrounds can get the condition; approximately 610,000 people die of heart disease in the US every year – that’s one in every four deaths.

Euromed's heritage is creating extracts that are used as medicines in Europe. Our new PhytoProof seal visually guarantees that consumers in the US and globally can easily identify products delivering the health benefits they're seeking.

Post this

Last year, the natural health industry saw a significant increase in scrutiny from consumers, the media, and from those within the industry itself. Now, more than ever, it is critical for consumers and manufacturers alike to use only ingredients that have been scientifically proven to work in published studies. This study highlights that the key factor in obtaining true health benefits from olive oil is the presence of a significant amount of the polyphenol, hydroxytryrosol. Euromed’s branded SOFE –Proliva® --contains 20% hydroxytyrosol as measured by HPLC ( High Performance Liquid Chromatography).

Not All Olive Oils Are Created Equal: European vs. US
Mediterranean populations have been extensively studied and found statistically to have lower levels of heart disease, even though their diet contains higher levels of dietary fat. But this daily intake of high levels of olive oil and olive fruit is believed to provide a protective effect against coronary heart disease due to the variety of phytochemicals, including polyphenols, they contain. The typical Mediterranean diet in Southern Europe provides a level of 5 to 10 milligrams of olive antioxidant polyphenols per day, with one of the most abundant polyphenols in olive oil being hydroxytyrosol.

Extra virgin olive oil (EVOO) is rich in hydroxytyrosol; yet it’s been reported that as much as 75-80% of EVOO in the US does not meet the European legal grade for EVOO. The UC Davis Olive Center in 2011 surveyed best-selling EVOOs on California store shelves and found they often failed sensory standards for EVOO. The oils were found to be oxidized, adulterated with cheaper refined oils, and contained poor quality oils due to poor processing and/ or improper storage. Therefore, health conscious consumers trying to incorporate olive oil into their diet may not be obtaining key olive oil components for a protective effect on heart health due to the low quality of oil available to them.

Today, a dietary supplement containing Proliva® SOFE will provide a level of hydroxytyrosol found in EVOO. This new study on Proliva® is the second clinical study showing a benefit for cardiovascular health and while more research is warranted, improved vessel elasticity and a reduction in triglycerides are benefits consumers can expect. “Proliva offers profound health benefits for consumers globally, particularly those unable to access quality EVOO in their diet,” stated Pilar Pais Ph.D., Technical Director of Euromed SA, located near Barcelona, Spain.

Science Tells the Story
The study is entitled: “Impact of a Proprietary Standardized Olive Fruit Extract (SOFE) on Cardio-Ankle Vascular Index, Visual Analog Scale and C-Reactive Protein Assessments in Subjects with Arterial Stiffness Risk.” The key findings from this human clinical trial are:

~ Proliva® was shown to improve blood vessel elasticity, and none was found in the placebo group;

~ Proliva® also demonstrated a reduction in serum triglycerides taking 500 mg per day;

~ Arterial stiffness is an important cardiovascular risk factor, assessed by CAVI (Cardio-Ankle Vascular Index) ... Proliva shows an ability to decrease the CAVI index which suggests that increasing C-HDL and lowering triglycerides with SOFE could potentially reduce patients' risk of developing atherosclerosis.

The link to see the entire study, complete with 56 references, is: https://www.ncbi.nlm.nih.gov/pubmed/27798770
Proliva®: The latest in Euromed’s PhytoProof® Line of Standardized Botanical Extract Ingredients
Euromed has created a proprietary PhytoProof® process – designated by its unique seal – to ensure consumer confidence that the ingredient found on product labels displaying this seal has undergone rigorous quality control. This includes authenticity and traceability as each production batch undergoes more than 20 laboratory tests from “field-to-finished extract.”

These laboratory test results are proof that each botanical extract batch is made correctly and in conformance with all the US FDA GMP requirements for identity, purity, composition, and strength. Manufacturers who include Euromed’s ingredients, and consumers who ingest them, are assured that they are getting the correct species, with NO adulteration and NO contamination by heavy metals, pesticides, aflatoxins, or other microbes – AND with the correct plant chemistry that assures the product will work safely and effectively.

Guy Woodman, General Manager of Euromed USA, states “Our heritage is making extracts that are used as medicines in Europe. We developed the PhtyoProof® seal so that consumers in the US and globally could easily identify products delivering the health benefits they are seeking.”

ABOUT EUROMED
Euromed supplies standardized botanical and herbal extracts and natural active substances for use in the dietary supplement, pharmaceutical, and cosmetics industries. By concentrating phytochemicals nature has provided, the company can guarantee that each batch of its extracts meets the same profile documented in clinical studies to be safe and effective. Euromed was founded 45 years ago; the company was recently acquired by The Riverside Company, with its US offices located in Presto, Pennsylvania. For additional information about Euromed’s extracts, call 877-696-3960 or email [email protected] and visit http://www.EuromedUSA.com.

Linda Roxanne Bryer, Bryer Advertising & Public Relations, http://www.BryerPR.com, +1 831-588-8767, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.